The medium‐sized cohort studies that have been performed have demonstrated the validity of the peripheral blood as a target for assessment, with changes including lower naïve B cells25 and clonally expanded CD8 T cells in patients with AD.21 This evidence concerns the gene CD8A and Alzheimer disease.